The volume and weight of tumor were significantly decreased in tumors combined with anti‐APOC2K70‐lac Ab or FX11 and anti‐PD‐1 mAb compared with single anti‐PD‐1 mAb treatment (Figure 8B–D). Here, PDCD1 is linked to neoplasm.